Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Novel agent for the detection of and assessment of the severity of myocardial ischemia with significantly reduced side effects to current marketed products More
1,2,4-benzothiadiazine derivatives useful for the treatment of endocrinological system diseases such as hyperinsulinaemia and diabetes. More
Vitamin C offered in 300mg doses More
This invention relates to a computer-controlled physiological flow simulator for use in the study of vascular hemodynamics and the calibration of clinical imaging systems used to measure blood flow More
K-134 is a drug with anti-platelet properties, which is expected to be useful in the treatment of patients with ischemic conditions. More
K604 is an cholesterol acyltransferase (ACAT) inhibitor contributing to the reduction of atherosclerotic lesion volume and ACS. More
Western inventors have identified a group of 12 differentially expressed proteins in Preeclampsia (PE) patients using a state-of-art proteomics based approach. More
This invention provides the human gene for Niemann-Pick Type C disease and the nucleic acid sequences corresponding to the human gene for Niemann-Pick Type C disease. More
Vitamin C offered in 500mg doses alone More
VEGF111, a novel naturally occurring isoform of human VEGF-A, was recently cloned. VEGF111 is active in terms of activation of VEGF receptors, induction of endothelial cells multiplication and stimulation of vascularisation in vitro and in vivo. As r More
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Angiogenesis
- Atherosclerosis
- Hypertension
- Hypotension
- Ischemia
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us